Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1551178rdf:typepubmed:Citationlld:pubmed
pubmed-article:1551178lifeskim:mentionsumls-concept:C0031327lld:lifeskim
pubmed-article:1551178lifeskim:mentionsumls-concept:C0014582lld:lifeskim
pubmed-article:1551178lifeskim:mentionsumls-concept:C1514228lld:lifeskim
pubmed-article:1551178lifeskim:mentionsumls-concept:C2827666lld:lifeskim
pubmed-article:1551178pubmed:issue5lld:pubmed
pubmed-article:1551178pubmed:dateCreated1992-4-29lld:pubmed
pubmed-article:1551178pubmed:abstractTextPopulation pharmacokinetic analysis of the anticancer agent epirubicin was carried out using the program NONMEM. Data were available from 36 patients aged 20-73 years, of whom 23 were women. All subjects exhibited normal liver and renal function. Epirubicin was given as a short-term i.v. infusion over the dose range of 25-100 mg/m2, and an average of 11 plasma samples/subject were taken for a period of up to 72 h after each dose. A Two compartment model was fitted to the data, characterised by the parameters clearance, volume of the central compartment, alpha and beta. Clearance was tested as a linear function of various demographic and/or biochemical features. A significant proportion of the variability in clearance could be attributed to sex, and also to age in women. For example, a 25-year-old man would display an average clearance of 95 l/h, whereas a 70-year-old woman would exhibit an average clearance of 64 l/h. Such differences in clearance might be important in the selection of epirubicin dose regimens.lld:pubmed
pubmed-article:1551178pubmed:languageenglld:pubmed
pubmed-article:1551178pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1551178pubmed:citationSubsetIMlld:pubmed
pubmed-article:1551178pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1551178pubmed:statusMEDLINElld:pubmed
pubmed-article:1551178pubmed:issn0344-5704lld:pubmed
pubmed-article:1551178pubmed:authorpubmed-author:RobertJJlld:pubmed
pubmed-article:1551178pubmed:authorpubmed-author:WhitingBBlld:pubmed
pubmed-article:1551178pubmed:authorpubmed-author:WadeJ RJRlld:pubmed
pubmed-article:1551178pubmed:authorpubmed-author:KelmanA WAWlld:pubmed
pubmed-article:1551178pubmed:authorpubmed-author:KerrD JDJlld:pubmed
pubmed-article:1551178pubmed:issnTypePrintlld:pubmed
pubmed-article:1551178pubmed:volume29lld:pubmed
pubmed-article:1551178pubmed:ownerNLMlld:pubmed
pubmed-article:1551178pubmed:authorsCompleteYlld:pubmed
pubmed-article:1551178pubmed:pagination391-5lld:pubmed
pubmed-article:1551178pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:1551178pubmed:meshHeadingpubmed-meshheading:1551178-...lld:pubmed
pubmed-article:1551178pubmed:meshHeadingpubmed-meshheading:1551178-...lld:pubmed
pubmed-article:1551178pubmed:meshHeadingpubmed-meshheading:1551178-...lld:pubmed
pubmed-article:1551178pubmed:meshHeadingpubmed-meshheading:1551178-...lld:pubmed
pubmed-article:1551178pubmed:meshHeadingpubmed-meshheading:1551178-...lld:pubmed
pubmed-article:1551178pubmed:meshHeadingpubmed-meshheading:1551178-...lld:pubmed
pubmed-article:1551178pubmed:meshHeadingpubmed-meshheading:1551178-...lld:pubmed
pubmed-article:1551178pubmed:meshHeadingpubmed-meshheading:1551178-...lld:pubmed
pubmed-article:1551178pubmed:meshHeadingpubmed-meshheading:1551178-...lld:pubmed
pubmed-article:1551178pubmed:meshHeadingpubmed-meshheading:1551178-...lld:pubmed
pubmed-article:1551178pubmed:meshHeadingpubmed-meshheading:1551178-...lld:pubmed
pubmed-article:1551178pubmed:meshHeadingpubmed-meshheading:1551178-...lld:pubmed
pubmed-article:1551178pubmed:meshHeadingpubmed-meshheading:1551178-...lld:pubmed
pubmed-article:1551178pubmed:meshHeadingpubmed-meshheading:1551178-...lld:pubmed
pubmed-article:1551178pubmed:meshHeadingpubmed-meshheading:1551178-...lld:pubmed
pubmed-article:1551178pubmed:meshHeadingpubmed-meshheading:1551178-...lld:pubmed
pubmed-article:1551178pubmed:year1992lld:pubmed
pubmed-article:1551178pubmed:articleTitleVariability in the pharmacokinetics of epirubicin: a population analysis.lld:pubmed
pubmed-article:1551178pubmed:affiliationDepartment of Medicine and Therapeutics, University of Glasgow, Gardiner Institute, Western Infirmary, UK.lld:pubmed
pubmed-article:1551178pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1551178pubmed:publicationTypeComparative Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1551178lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1551178lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1551178lld:pubmed